Complete downmodulation of P-selectin glycoprotein ligand in monocytes undergoing apoptosis

Jan-Julius Stampfuss1, Petra Censarek, Jens W Fischer

  • 1Institut für Pharmakologie, Universität Duisburg-Essen, Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen, Germany.

Abstract

Insights

Apoptotic monocytes shed P-selectin glycoprotein ligand-1 (PSGL-1), reducing cell interactions and thrombogenicity. This shedding is mediated by an ADAM metalloproteinase, suggesting a mechanism to control inflammation and clotting.

Area of Science:

  • Cell Biology
  • Immunology
  • Hematology

Background:

  • Apoptotic monocytes release microparticles implicated in thrombosis via P-selectin glycoprotein ligand-1 (PSGL-1).
  • Understanding PSGL-1 regulation in apoptosis is crucial for its role in thrombogenicity.

Purpose of the Study:

  • To systematically investigate the regulation of PSGL-1 expression and function in apoptotic monocytic cells.
  • To identify the mechanism and enzyme responsible for PSGL-1 downmodulation during monocyte apoptosis.

Main Methods:

  • Flow cytometry, immunofluorescence microscopy, and immunoblotting to assess PSGL-1 expression.
  • Platelet-leukocyte and leukocyte-endothelial cell interaction assays.
  • Protease inhibitor screening, knock-out, and siRNA experiments to identify the cleaving enzyme.

Main Results:

  • PSGL-1 expression was significantly reduced in apoptotic monocytes due to proteolytic shedding.
  • This shedding led to a complete loss of PSGL-1-mediated platelet-leukocyte and leukocyte-endothelial cell interactions.
  • An ADAM metalloproteinase, inhibited by N-ethylmaleimide, was identified as the enzyme responsible for PSGL-1 cleavage.

Conclusions:

  • Downregulation of PSGL-1 on apoptotic monocytes may prevent inappropriate cell clearance, reducing vascular inflammation and proliferation.
  • PSGL-1 depletion on apoptotic microparticles may serve as a molecular switch modulating their thrombogenic potential.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...